• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » May 1999 – The CenterWatch Monthly : PDF
May 1999 – The CenterWatch Monthly : PDF

May 1999 – The CenterWatch Monthly : PDF

$79.00

Product Details

The Ups and Downs of SMO Usage

SMO usage is growing steadily. However, sponsor and CROs are primarily using SMOs to gain access to top sites.

SMOs appear to be outperforming independent sites in study initiation. But SMOs are more expensive.

A New Market in Long Term Care

The FDA's Geriatric Use Labeling Rule will require drug labeling information for patients aged 65 and over to be phase in over a six-year period. As a result, the need for clinical research among the elderly is expected to grow rapidly.

A number of progressive nursing homes with strong links to university medical centers are leading the way in clinical trials among the elderly. Several large players, including Omnicare-IBAH have now moved into this market.

Also in this issue:

  • Eye On Osteoporosis

 

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing